Concepedia

Sariah Kell

SK

6

Publications

314

Citations

6

H-Index

2004

Active since

Affiliations

Dynavax Technologies (United States)(Current)

National Institutes of Health

Sariah Kell is an author at Dynavax Technologies (United States) specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2004–2018

6

Publications

6

Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction

Edith M. Hessel, Mabel Chu, Jennifer O. Lizcano et al. · The Journal of Experimental Medicine · 2005 · 117 citations · Full text

, , +15

Follicular Dendritic Cell Regulation of CXCR4-Mediated Germinal Center CD4 T Cell Migration

Jacob D. Estes, Tyler C. Thacker, Denise L. Hampton et al. · The Journal of Immunology · 2004 · 75 citations · Full text

A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice

John D. Campbell, Sariah Kell, Heather M. Kozy et al. · Thorax · 2014 · 40 citations · Full text

First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated

Sam Jackson, Albert F. Candia, Stephen Delaney et al. · Clinical Pharmacology & Therapeutics · 2017 · 29 citations

A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys

Melissa A. Kachura, Colin L. Hickle, Sariah Kell et al. · The Journal of Immunology · 2015 · 27 citations · Full text

, , +17

Rows per page

1–5 of 6